Clinical and genomic characteristics of primary resistant disease to first-line immuno-oncology plus VEGFR inhibitor therapy in metastatic renal cell carcinoma
- DOI
- 10.1038/s41598-026-59145-y
- Published
- 2026-06-30
- Container
- Scientific Reports
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41598-026-59145-y,
title = {Clinical and genomic characteristics of primary resistant disease to first-line immuno-oncology plus VEGFR inhibitor therapy in metastatic renal cell carcinoma},
author = {Kohei Kobatake and Keisuke Goto and Yohei Sekino and Kazuma Yukihiro and Miki Naito and Kenshiro Takemoto and Shunsuke Miyamoto and Hiroyuki Kitano and Akihiro Goriki and Keisuke Hieda and Nobuyuki Hinata},
year = {2026},
journal = {Scientific Reports},
doi = {10.1038/s41598-026-59145-y},
url = {https://doi.org/10.1038/s41598-026-59145-y}
}RIS
TY - JOUR TI - Clinical and genomic characteristics of primary resistant disease to first-line immuno-oncology plus VEGFR inhibitor therapy in metastatic renal cell carcinoma AU - Kohei Kobatake AU - Keisuke Goto AU - Yohei Sekino AU - Kazuma Yukihiro AU - Miki Naito AU - Kenshiro Takemoto AU - Shunsuke Miyamoto AU - Hiroyuki Kitano AU - Akihiro Goriki AU - Keisuke Hieda AU - Nobuyuki Hinata PY - 2026 JO - Scientific Reports DO - 10.1038/s41598-026-59145-y UR - https://doi.org/10.1038/s41598-026-59145-y ER -
APA
Kobatake, K., Goto, K., Sekino, Y., Yukihiro, K., Naito, M., Takemoto, K., Miyamoto, S., Kitano, H., Goriki, A., Hieda, K., & Hinata, N. (2026). Clinical and genomic characteristics of primary resistant disease to first-line immuno-oncology plus VEGFR inhibitor therapy in metastatic renal cell carcinoma. Scientific Reports. https://doi.org/10.1038/s41598-026-59145-y
Source records
- crossref · retrieved 2026-09-25T21:30:31.735Z